Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis.
about
Mesenchymal-to-endothelial transition in Kaposi sarcoma: a histogenetic hypothesis based on a case series and literature reviewHighlights on endoglin (CD105): from basic findings towards clinical applications in human cancerNon-viral VEGF(165) gene therapy--magnetofection of acoustically active magnetic lipospheres ('magnetobubbles') increases tissue survival in an oversized skin flap model.Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma.Particular distribution and expression pattern of endoglin (CD105) in the liver of patients with hepatocellular carcinoma.Endoglin in liver fibrogenesis: Bridging basic science and clinical practiceThe role of microvessel density, lymph node metastasis, and tumor size as prognostic factors of distant metastasis in colorectal cancer.Identification of chemokines and growth factors in proliferative diabetic retinopathy vitreous.Clinicopathological significance of stromal variables: angiogenesis, lymphangiogenesis, inflammatory infiltration, MMP and PINCH in colorectal carcinomas.Role of endoglin and VEGF family expression in colorectal cancer prognosis and anti-angiogenic therapies.Anti-tumor activity of an anti-endoglin monoclonal antibody is enhanced in immunocompetent mice.Anti-endoglin monoclonal antibodies are effective for suppressing metastasis and the primary tumors by targeting tumor vasculature.Prognostic Significance of Microvessel Density Determining by Endoglin in Stage II Rectal Carcinoma: A Retrospective AnalysisPerfusion CT in colorectal cancer: comparison of perfusion parameters with tumor grade and microvessel densityAn open-label phase Ib dose-escalation study of TRC105 (anti-endoglin antibody) with bevacizumab in patients with advanced cancer.Delivery of antiangiogenic agents for cancer gene therapy.Plasma biomarkers of clinical response during chemotherapy plus combination antiretroviral therapy (cART) in HIV+ patients with advanced Kaposi sarcomaMicrovessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature.Blood vessel maturation in human uveal melanoma: spatial distribution of neovessels and mature vasculatureClinical impact and network of determinants of tumour necrosis in colorectal cancerCurrent status and issues in cancer stem cell study.Hypoxia-inducible factor-1alpha and -2alpha are expressed in most rectal cancers but only hypoxia-inducible factor-1alpha is associated with prognosis.ENDOGLIN/CD105 is expressed in KIT positive cells in the gut and in gastrointestinal stromal tumoursLocally advanced rectal cancer: from molecular profiling to clinical practice. A literature review: Part 2.Endoglin-targeted cancer therapy.Hypoxic and highly angiogenic non-tumor tissues surrounding hepatocellular carcinoma: the 'niche' of endothelial progenitor cells.TGF-β and its coreceptors in cancerogenesis: an overview.Understanding and targeting resistance to anti-angiogenic therapies.Endoglin for targeted cancer treatment.Immunohistochemical analysis of vascular density and area in colorectal carcinoma using different markers and comparison with clinicopathologic prognostic factors.Hepatitis C Virus Core Protein Modulates Endoglin (CD105) Signaling Pathway for Liver Pathogenesis.Circulating CD105 shows significant impact in patients of oral cancer and promotes malignancy of cancer cells via CCL20.Soluble MMP-14 produced by bone marrow-derived stromal cells sheds epithelial endoglin modulating the migratory properties of human breast cancer cells.(89)Zr-labeled anti-endoglin antibody-targeted gold nanoparticles for imaging cancer: implications for future cancer therapy.Characterization of murine S-endoglin isoform and its effects on tumor development.Soluble endoglin antagonizes Met signaling in spindle carcinoma cells.Tumor angiogenesis as prognostic and predictive marker for chemotherapy dose-intensification efficacy in high-risk breast cancer patients within the WSG AM-01 trial.Expression of cyclooxygenase-2, glucose transporter-1 and angiogenesis in gallbladder carcinomas and their impact on prognosis.Role of VEGF, CD105, and CD31 in the Prognosis of Colorectal Cancer Cases.Soluble Endoglin (CD105) Serum Level as a Potential Marker in the Management of Head and Neck Paragangliomas.
P2860
Q21132551-03E814B8-FC26-4485-934F-6E128A995EABQ24798737-C7F79252-BE18-44B3-AAEB-07EDF0C5F4E6Q30414052-2D90090F-44F5-42EC-8075-AD4DDC123C14Q33241639-CE393CF2-AD6B-4CC8-92DB-516E745C610BQ33289829-536F8C2D-9E6A-4449-A2B6-E091B42ABB67Q33728841-D238E4D1-2C64-45B4-9BDB-25A2A1EF1EE3Q33751209-33452E3E-EB5B-4EA4-A53E-1D82140886BCQ34481203-E59BF944-BCE6-43D9-B342-55C7F8CD9965Q35104008-7FBD7F0A-82E7-433F-9120-277F7D021AA0Q35113402-5F35B989-8349-4DD6-8540-2766D31E0B20Q35157425-4661392D-06F5-4C5A-A0FB-92C6938C2902Q35201283-7805C16D-832B-4421-85AA-1A197FE651AEQ35680766-59F554CF-D282-4A83-A2A5-CB051BC966F4Q35925855-7370F59C-F56C-48F6-A3F7-2F1322871EBDQ36061812-3C818262-34C6-43BD-83B6-F2B6F7B20176Q36200143-6F8A103B-427E-451F-BCEC-6F1C86D18046Q36557592-EFECC97D-C551-4A63-9E66-B386DCA8F340Q36614453-12EEFDBB-DF4E-4459-8AFD-16E69E4C6BC9Q37020248-8B386340-6953-4E74-B290-AD2269EEEEDBQ37174042-B2A45F06-262D-47C0-AC29-1A5BBE50F72EQ37209811-F0EF66B1-C434-4BCB-A1D2-CBB816FD15C2Q37228454-AFDBD7D5-EB05-4A73-B0D1-9FB27C8DBA85Q37295765-E49B112C-4537-46B8-B5BC-52F3C39760C0Q37598888-ECD66366-B219-4B5B-A810-720C0E85326FQ37804900-64ACFF0F-BE03-450E-9F37-A2EAA70EDD6CQ37820212-3AAFDA0A-F322-4065-AD43-D0EBB4ECCC9AQ37959017-513DD7BB-1983-4E16-915E-BCC3F995D820Q38133568-B0F0E5BE-B6D9-4945-9F03-3CD3DA5BE606Q38180309-98E06875-50B6-4A06-8F7B-B4CEE892AB18Q38412668-491BDDFD-7454-451F-BD39-8DD4945A4306Q38631740-E4B82DB1-5D9F-4BEA-BC0E-26D10F8BD0E6Q38838413-DC346FAC-B1EA-4E9A-9A78-FE5D07A0DAF4Q39016514-AAF9383D-D639-4BAB-9B4A-0BFD262F57E6Q39023017-D04A84D0-7F04-4AE0-BBC6-4022DB9F4292Q40439634-59B76F16-3B89-4DFC-9AF2-ED1D950F1AB9Q42470252-A8FB97BA-CD33-4B32-AB0F-8D3082C470BEQ42483948-20FD9679-3745-44B6-BD3A-537FAAB6EBBEQ45928109-1F4F47AF-424A-46BF-8920-BBDC6A66B0B2Q46530152-58E893D2-0A60-4200-95DF-EC2B1297E311Q47869338-37CDEDC2-78B1-470D-B72F-D9383624942A
P2860
Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2003
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Both high intratumoral microve ...... correlate with poor prognosis.
@en
Both high intratumoral microve ...... correlate with poor prognosis.
@nl
type
label
Both high intratumoral microve ...... correlate with poor prognosis.
@en
Both high intratumoral microve ...... correlate with poor prognosis.
@nl
prefLabel
Both high intratumoral microve ...... correlate with poor prognosis.
@en
Both high intratumoral microve ...... correlate with poor prognosis.
@nl
P2093
P2860
P921
P356
P1476
Both high intratumoral microve ...... correlate with poor prognosis.
@en
P2093
S T O'Dwyer
P2860
P2888
P304
P356
10.1038/SJ.BJC.6600874
P407
P577
2003-05-01T00:00:00Z
P5875
P6179
1025145104